AI-generated summary
The authors studied 21 patients with atrophic facial acne scars in Iraq who received three sessions of fractional 1540 nm erbium glass laser at two-week intervals. Scar grade and visual analog scale scores improved in some patients over six months of follow-up, and most reported varying satisfaction. The authors describe the treatment as effective and safe, but the study was small, prospective, and uncontrolled.
- Participants
- 21
- Who or what was studied
- Iraqi patients with atrophic facial acne scars
- Wavelengths
- 1540 nm
- Limits stated in the abstract
- The abstract reports a small, uncontrolled clinical study with two patients lost to follow-up and no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1540 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.